Final results from the RA-BEYOND study show that patients with rheumatoid arthritis can often maintain disease control after tapering baricitinib from 4 mg to 2 mg.

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

The same chemicals and receptors that control the sensation of pain in the opioid system also play a role in regulating ...